Zeposia HCP Marketing Brand Lead @ Bristol-Myers Squibb (Formerly Celgene) (January 2021 - September 2022)
Regional Marketing @ (April 2019 - December 2020)
HCP Marketing and Channel Strategy Lead - Soliqua 100 and 33 and Adlyxin @ (January 2015 - March 2019)
INOMAX US Marketing @ (January 2015 - January 2015)
Managing Director @ Veraxis Health Communications (January 2010 - January 2015)
Director HCP Marketing NovoLog Mix 70 and 30 @ (January 2007 - January 2010)
Respiratory Marketing and Commercialization and Alliance Management @ (January 2004 - January 2007)
Dermatology and Pediatric Franchise Marketing and Sales Management @ (January 2003 - January 2004)
Marketing, Sales and Sales Leadership @ (January 1995 - January 2002)
Account Manager @ (January 1993 - January 1995)
Anthony D'Urso Education
Seton Hall University 1989-1993
St Marys High School 1984-1990
Anthony D'Urso Skills
Marketing Strategy
Product Development
Strategic Planning
Commercialization
Lifesciences
Product Launch
Diabetes
Pharmaceutical Sales
Product Marketing
Global Marketing
Medical Devices
Dermatology
Allergy
Neurology
Endocrinology
Pulmonology
Rheumatology
Strategy
Clinical Development
Pharmaceutical Industry
Cross-functional Team Leadership
Market Research
Infection
Respiration
Healthcare
Managed Care
Marketing
Life Sciences
Cardiology
Medical Affairs
Market Planning
Biotechnology
Cross Functional Team Leadership
Microsoft Excel
Sales Management
Clinical Research
Customer Service
Anthony D'Urso Summary
Anthony D'Urso, based in New York, NY, US, is currently a Regional Sales at Neurocrine Biosciences. Anthony D'Urso brings experience from previous roles at Provepharm, 822 Consulting, Bristol-Myers Squibb (Formerly Celgene) and Celgene. Anthony D'Urso holds a 1989 - 1993 Seton Hall University. With a robust skill set that includes Marketing Strategy, Product Development, Strategic Planning, Commercialization, Lifesciences and more. Anthony D'Urso has 3 emails on RocketReach.
Looking for a different Anthony D'Urso?
Find contact details for 700 million professionals.